VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve 1. Un-Audited financial results for the quarter ended 31.12.2024.2. Limited Review Report for quarter ended 31.12.2024.3. Any other business with the permission of the Chair.